Masatoshi Haruta
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 24, 2024
Multiple retinal vein thrombi after an intravitreal aflibercept 8 mg injection for age-related macular degeneration.Masatoshi Haruta, Shotaro Dake, Shigeo Yoshida
|Apr 25, 2023
Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration.Nobuhiro Kato, Masatoshi Haruta, Kei Furushima
|Jan 26, 2023
Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema.Junichi Itou, Kei Furushima, Masatoshi Haruta
|Apr 08, 2022
Branch Retinal Artery Occlusions, Paracentral Acute Middle Maculopathy and Acute Macular Neuroretinopathy After COVID-19 Vaccinations.Koki Ishibashi, Hiroyuki Yatsuka, Masatoshi Haruta
|Sep 01, 2021
Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy.Yu Matsuo, Masatoshi Haruta, Yumi Ishibashi
|Jan 28, 2021
Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients.Koki Ishibashi, Masatoshi Haruta, Yumi Ishibashi
Pageof 2
